In this context, we have previously shown that a novel strategy using an MYCN-specific antigene peptide nucleic acid (agPNA) oligonucleotide (called BGA002) is effectively able to silence MYCN expression by acting directly at the DNA level in neuroblastoma (NB) [33,34,35,36]. This evidence concerns the gene MYCN and neuroblastoma.